HTRS provides two-year mentored research awards for young investigators pursuing clinical or basic science research careers in benign hematology (or areas of medicine with a major component of benign hematology.)
Learn More
Grants to HTRS from Novo Nordisk Inc. support one-year clinical scholarships in hemophilia and rare bleeding disorders for trainees working under the guidance of an experienced mentor at U.S.-based academic universities or hemophilia/thrombosis treatment centers.
This award, offered jointly by HTRS and the American Thrombosis and Hemostasis Network (ATHN) and supported by Takeda and Hemophilia of Georgia, enables young investigators residing in the U.S. to work with ATHN-affiliated, U.S.-based hemophilia treatment centers to conduct research using the national ATHNdataset under the guidance of experienced mentors.
HTRS provides grants to support up to $1,500 in travel and lodging, plus complimentary meeting registration fees for young investigators who submit the highest scoring abstracts to be displayed as posters at HTRS Scientific Symposia.
The HTRS Mid-Career Research Award (MCRA) Program provides financial support for mid-career investigators pursuing clinical, translational, or basic science research projects in hemostasis and/or thrombosis. Applicants must be working in the United States or Canada for the duration of the proposed project.
This award is presented during HTRS Scientific Symposia to recognize lasting and extraordinary career contributions in hemostasis and thrombosis.
This award, named in honor of a founding member and longtime Treasurer of HTRS, Dr. Joan Cox Gill, recognizes outstanding service by an HTRS member toward advancing the Society’s strategic goals and programs.
Contact Jennifer Ziegler, Director, Awards Programs and Career Development, [email protected].